Balance Sheet of Ranbaxy Laboratories ------------------- in Rs. Cr.

-------------------
Mar '14 Dec '12 Dec '11 Dec '10 Dec '09

15 mths 12 mths 12 mths 12 mths 12 mths

Sources Of Funds
Total Share Capital 211.66 211.46 211.00 210.52 210.21
Equity Share Capital 211.66 211.46 211.00 210.52 210.21
Share Application Money 0.50 1.11 0.67 6.60 175.85
Preference Share Capital 0.00 0.00 0.00 0.00 0.00
Reserves 884.83 1,709.51 1,713.16 4,915.28 3,748.54
Networth 1,096.99 1,922.08 1,924.83 5,132.40 4,134.60
Secured Loans 1,011.75 944.18 229.59 195.39 175.83
Unsecured Loans 4,979.31 3,819.43 3,653.82 4,065.33 3,172.55
Total Debt 5,991.06 4,763.61 3,883.41 4,260.72 3,348.38
Total Liabilities 7,088.05 6,685.69 5,808.24 9,393.12 7,482.98
Mar '14 Dec '12 Dec '11 Dec '10 Dec '09

15 mths 12 mths 12 mths 12 mths 12 mths

Application Of Funds
Gross Block 3,337.81 3,118.22 2,886.15 2,857.63 2,620.92
Less: Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
Less: Accum. Depreciation 1,325.67 1,124.69 1,019.15 1,145.52 1,027.52
Net Block 2,012.14 1,993.53 1,867.00 1,712.11 1,593.40
Capital Work in Progress 183.63 159.60 209.12 330.18 414.92
INVESTMENTS 4,080.88 3,131.17 3,410.79 3,804.44 3,833.69
Inventories 1,695.14 1,731.84 1,655.23 1,489.91 1,230.48
Sundry Debtors 1,237.47 1,435.89 3,682.82 1,292.63 1,534.65
Cash and Bank Balance 790.57 2,834.77 1,937.95 22.44 25.56
Total Current Assets 3,723.18 6,002.50 7,276.00 2,804.98 2,790.69
Loans and Advances 3,105.21 1,683.14 1,558.01 1,470.45 1,967.65
Fixed Deposits 0.00 0.00 0.00 2,689.85 728.56
Total CA, Loans & Advances 6,828.39 7,685.64 8,834.01 6,965.28 5,486.90
Deferred Credit 0.00 0.00 0.00 0.00 0.00
Current Liabilities 5,696.72 3,227.24 5,583.81 2,491.08 3,082.89
Provisions 320.26 3,057.02 2,928.87 927.82 763.03
Total CL & Provisions 6,016.98 6,284.26 8,512.68 3,418.90 3,845.92
Net Current Assets 811.41 1,401.38 321.33 3,546.38 1,640.98
Miscellaneous Expenses 0.00 0.00 0.00 0.00 0.00
Total Assets 7,088.06 6,685.68 5,808.24 9,393.11 7,482.99

Contingent Liabilities 1,222.20 789.63 927.85 276.13 261.05

Book Value (Rs) 25.87 45.42 45.60 121.74 94.16
Profit & Loss account of Ranbaxy Laboratories ------------------- in Rs. Cr. -------------------
Profit &
Mar '14 Dec '12 Dec '11 Dec '10 Dec
loss

15 mths 12 mths 12 mths 12 mths 12 mt

Income
Sales Turnover 6,864.94 6,303.54 7,799.06 5,687.33 4,797.
Excise Duty 0.00 0.00 0.00 40.96 15.
Net Sales 6,864.94 6,303.54 7,799.06 5,646.37 4,781.
Other Income 303.28 -124.07 -3,549.63 562.45 485.
Stock Adjustments 175.12 49.25 135.72 161.43 33.
Total Income 7,343.34 6,228.72 4,385.15 6,370.25 5,301.
Expenditure
Raw Materials 3,182.54 2,453.09 2,523.08 2,181.22 1,916.
Power & Fuel Cost 304.27 230.91 194.98 132.75 109.
Employee Cost 1,274.73 1,019.59 860.71 608.28 582.
Other Manufacturing Expenses 0.00 0.00 0.00 96.68 89.
Selling and Admin Expenses 0.00 0.00 0.00 1,332.70 1,306.
Miscellaneous Expenses 2,603.01 2,206.28 3,281.97 185.14 158.
Preoperative Exp Capitalised 0.00 0.00 0.00 0.00 0.
Total Expenses 7,364.55 5,909.87 6,860.74 4,536.77 4,162.
Mar '14 Dec '12 Dec '11 Dec '10 Dec '

15 mths 12 mths 12 mths 12 mths 12 mt

Operating Profit -324.49 442.92 1,074.04 1,271.03 652.

PBDIT -21.21 318.85 -2,475.59 1,833.48 1,138.
Interest 547.05 296.98 299.00 54.19 39.
PBDT -568.26 21.87 -2,774.59 1,779.29 1,098.
Depreciation 280.17 186.16 274.08 228.35 148.
Other Written Off 0.00 0.00 0.00 0.00 0.
Profit Before Tax -848.43 -164.29 -3,048.67 1,550.94 950.
Extra-ordinary items 0.00 0.00 0.00 21.88 111.
PBT (Post Extra-ord Items) -848.43 -164.29 -3,048.67 1,572.82 1,062.
Tax 30.57 -1.94 3.38 415.48 488.
Reported Net Profit -879.00 -162.34 -3,052.05 1,148.73 571.
Total Value Addition 4,182.01 3,456.78 4,337.66 2,355.55 2,246.
Preference Dividend 0.00 0.00 0.00 0.00 0.
Equity Dividend 0.00 0.00 0.00 84.21 0.
Corporate Dividend Tax 0.00 0.00 0.00 13.99 0.
Per share data (annualised)
Shares in issue (lakhs) 4,237.79 4,229.14 4,220.00 4,210.41 4,204.
Earning Per Share (Rs) -20.74 -3.84 -72.32 27.28 13.
Equity Dividend (%) 0.00 0.00 0.00 40.00 0.
Book Value (Rs) 25.87 45.42 45.60 121.74 94.

Source : Dion Global Solutions Limited

BSE
NSE